Table 1. A univariate analysis of factors affecting the overall survival rate.
Univariate analysis | |||
---|---|---|---|
N | 5-year survival rate (%) | P value | |
Age (years) | <0.001 | ||
<65 | 570 | 69.6 | |
≥65 | 947 | 56.9 | |
Gender | <0.001 | ||
Male | 1055 | 59.2 | |
Female | 462 | 67.0 | |
Tumor size | <0.001 | ||
< 5 cm | 816 | 77.7 | |
≥ 5 cm | 701 | 42.8 | |
Lymphovascular invasion | <0.001 | ||
Absent | 716 | 81.9 | |
Present | 801 | 43.5 | |
7th AJCC edition pTNM stage | <0.001 | ||
Stage IA | 450 | 88.5 | |
Stage IB | 166 | 81.9 | |
Stage IIA | 188 | 73.5 | |
Stage IIB | 156 | 68.9 | |
Stage IIIA | 150 | 47.3 | |
Stage IIIB | 243 | 24.1 | |
Stage IIIC | 164 | 15.4 | |
8th AJCC edition pTNM stage | <0.001 | ||
Stage IA | 450 | 88.5 | |
Stage IB | 166 | 81.9 | |
Stage IIA | 188 | 73.5 | |
Stage IIB | 153 | 69.0 | |
Stage IIIA | 200 | 42.1 | |
Stage IIIB | 171 | 26.9 | |
Stage IIIC | 189 | 13.6 |